Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Lee-Ying R"'
Autor:
Wong R; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Anderson B; Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada., Bashir B; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Bateman J; Royal Alexandra Hospital, Edmonton, AB T5H 3V9, Canada., Chalchal H; Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada., Davies J; BC Cancer Centre, Vancouver, BC V5Z 4E6, Canada., Dehmoobed A; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Geller G; BC Cancer Centre, Victoria, BC V8R 6V5, Canada., Ghose A; Chinook Regional Hospital, Lethbridge, AB T1J 1W5, Canada., Gill S; BC Cancer Centre, Vancouver, BC V5Z 4E6, Canada., Gordon V; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Green S; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Hebbard P; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Iqbal M; Saskatchewan Cancer Agency, Regina, SK S4T 7T1, Canada., Ji S; Shared Health Manitoba, Winnipeg, MB R2N 0E2, Canada., Karachiwala H; Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada., Kidane B; Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3A 1R9, Canada., Kim C; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Kosyachkova E; My Gut Feeling-Stomach Cancer Foundation of Canada, Toronto, ON M5A 4T7, Canada., Krahn M; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Krishnan T; BC Cancer Centre, Vancouver, BC V5Z 4E6, Canada., Kristjanson M; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Lee S; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Lee-Ying R; Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada., Lelond S; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Liu HW; Central Alberta Cancer Center, Red Deer, AB T4N 6R2, Canada., Meyers D; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Mulder K; Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada., Paul J; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Planincic E; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Oct 07; Vol. 31 (10), pp. 5987-6006. Date of Electronic Publication: 2024 Oct 07.
Autor:
Patrikidou A; Department of Medical Oncology and Early Drug Development Department, Gustave Roussy Institute, Villejuif, France., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy., Lee-Ying R; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zarif TE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Davidsohn M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Rossetti S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Ottanelli C; University of Florence, Florence, Italy., Andrade L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Gennusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Pignata S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Ravi P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Tom Baker Cancer Centre, Calgary, Alberta, Canada., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy., Fizazi K; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct 05; Vol. 22 (6), pp. 102230. Date of Electronic Publication: 2024 Oct 05.
Autor:
Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy., Lee-Ying R; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Rossetti S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., Davidsohn M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Oliveira TM; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Malgeri A; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy., Modesti M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ravi P; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Pignata S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102185. Date of Electronic Publication: 2024 Aug 09.
Autor:
Xu Y; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada., Chow R; Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada., Murdy K; Faculty of Law, University of Calgary, Calgary, AB T2N 1N4, Canada., Mahsin M; Precision Oncology Hub, Arnie Charbonneau Cancer Institute, Calgary, AB T2N 4Z6, Canada., Chandereng T; Northwell Health, New Hyde Park, NY 11030, USA., Sinha R; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada., Lee-Ying R; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada., Abedin T; Clinical Research Unit, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada., Cheung WY; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada., Thanh NX; Strategic Clinical Networks, Alberta Health Services, Calgary, AB T5J 3E4, Canada.; School of Public Health, University of Alberta, Edmonton, AB T6G 2R3, Canada., Lee SL; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 15; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 15.
Autor:
Ko JJ; Department of Medical Oncology, University of British Columbia, BC Cancer - Abbotsford, Abbotsford, BC, Canada., Mbuagbaw L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada., Tyldesley S; Department of Radiation Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada., Lowther J; Medical Affairs, Bayer Inc., Mississauga, ON, Canada., Sunderland K; Division of Cancer Surveillance and Outcomes, BC Cancer - Vancouver, Vancouver, BC, Canada., Royer C; PeriPharm Inc., Montreal, QC, Canada., Faure M; PeriPharm Inc., Montreal, QC, Canada., MacPhail C; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada., Faizi S; Vancouver Fraser Medical Program, University of British Columbia, Vancouver, BC, Canada., Cheung WY; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Lee-Ying R; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2024 Jul; Vol. 18 (7), pp. E194-E203.
Autor:
Samnani S; Department of Internal Medicine, University of Calgary, Calgary, AB, Canada., Ding PQ; Oncology Outcomes, University of Calgary, Calgary, AB, Canada., Lee-Ying R; Department of Oncology, University of Calgary, Calgary, AB, Canada., Cheung WY; Oncology Outcomes, University of Calgary, Calgary, AB, Canada.; Department of Oncology, University of Calgary, Calgary, AB, Canada., Karim S; Oncology Outcomes, University of Calgary, Calgary, AB, Canada.; Department of Oncology, University of Calgary, Calgary, AB, Canada.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jun 24, pp. OP2400060. Date of Electronic Publication: 2024 Jun 24.
Autor:
Hussain M; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Wong C; Faculty of Arts, Department of Psychology, University of Calgary, Calgary, AB T2N 1N4, Canada., Taguedong E; Department of Medicine, McGill University, Montreal, QC H3A 0G4, Canada., Verma S; London Regional Cancer Program, Department of Medical Oncology, London Health Sciences Centre, London, ON N6A 5W9, Canada., Mahsin M; Precision Oncology Hub, Alberta Health Services, Calgary, AB T2N 4Z6, Canada., Karim S; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Lee-Ying R; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Ezeife DA; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Aug 18; Vol. 30 (8), pp. 7706-7712. Date of Electronic Publication: 2023 Aug 18.
Autor:
Ding PQ; Oncology Outcomes Program, Department of Oncology, University of Calgary, Calgary, AB T2N 4Z6, Canada.; Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada., Au F; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada., Cheung WY; Oncology Outcomes Program, Department of Oncology, University of Calgary, Calgary, AB T2N 4Z6, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N2, Canada., Heitman SJ; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada., Lee-Ying R; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N2, Canada.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Aug 16; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 16.
Autor:
Le, D.M., Ahmed, S., Brunet, B., Davies, J., Doll, C., Ferguson, M., Ginther, N., Gordon, V., Hamilton, T., Hebbard, P., Helewa, R., Kim, C.A., Lee-Ying, R., Lim, H., Loree, J.M., McGhie, J.P., Mulder, K., Park, J., Renouf, D., Wong, R.P.W., Zaidi, A., Asif, T.
Publikováno v:
Current Oncology
Volume 26
Issue 6
Pages 5517-784
Volume 26
Issue 6
Pages 5517-784
The 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference was held in Saskatoon, Saskatchewan, 28&ndash
29 September 2018. This interactive multidisciplinary conference is attended by health care professionals from across Wes
29 September 2018. This interactive multidisciplinary conference is attended by health care professionals from across Wes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::8701409eef563f804ca6923173f044b8
Autor:
Watson AS; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada., Gagnon R; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada., Batuyong E; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada., Alimohamed N; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada., Lee-Ying R; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada. Electronic address: richard.lee-ying@albertahealthservices.ca.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Oct; Vol. 20 (5), pp. 496.e1-496.e9. Date of Electronic Publication: 2022 Apr 26.